To determine whether a personalized messaging intervention improves blood pressure control compared to usual care in post-PCI patients, specifically measuring the primary outcome of blood pressure levels.
Key Findings:
The personalized messaging intervention improved blood pressure control compared to usual care (specific statistical results). Higher engagement with the app was positively associated with achieving CV risk-factor targets.
Interpretation:
The study suggests that a lightweight, personalized messaging intervention can enhance secondary prevention efforts in post-PCI patients, potentially improving health outcomes.
Limitations:
Participants could not be fully blinded due to the nature of the intervention. The study was conducted at only two sites in Korea, which may limit generalizability. Potential biases or confounding factors were not fully addressed.
Conclusion:
AnSim, a smartphone-based messaging program, effectively supports post-PCI secondary prevention by improving blood pressure control and encouraging patient engagement, with implications for enhancing clinical practice.
Data presented at the American College of Cardiology 75th Annual Scientific Session linked pregnancy-associated SCAD to more severe presentation and higher in-hospital major adverse cardiovascular events.
